Clinical Trials Browser

Phase 1 × lorvotuzumab mertansine × Plasma cell × Clear all

NCT00991562 2014-11-21

IMGN901 in Combination With Lenalidomide and Dexamethasone

Phase 1 Completed

Multiple Myeloma, Recurrence

NCT00346255 2013-04-23

IMGN901

Phase 1 Completed

Multiple Myeloma